ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For RCC"
Episode Synopsis
At the conclusion of this activity, participants will be able to:
1. Explain the sequencing of novel therapies and be able to identify patient progression of disease.
2. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological agents for the treatment of kidney cancer.
This educational series is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Pfizer, Inc
Sanofi Genzyme
UroGen Pharma, Inc.
CME Available: auau.auanet.org/node/29811
1. Explain the sequencing of novel therapies and be able to identify patient progression of disease.
2. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological agents for the treatment of kidney cancer.
This educational series is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Pfizer, Inc
Sanofi Genzyme
UroGen Pharma, Inc.
CME Available: auau.auanet.org/node/29811
More episodes of the podcast AUAUniversity
Core Curriculum: Anorectal Malformation
22/10/2025
The Latest Breakthroughs in mHSPC
24/09/2025
In God we trust